Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 10:1-7.
doi: 10.1007/s13410-022-01166-0. Online ahead of print.

A study to evaluate the knowledge, vaccination status and acceptance of adult vaccinations against respiratory infections in patients with type 2 diabetes in South India

Sumana Kunnuru  1 , Vandana Godella  2 , Shanthan Vinala  3 , Beatrice Anne  1
Affiliations

A study to evaluate the knowledge, vaccination status and acceptance of adult vaccinations against respiratory infections in patients with type 2 diabetes in South India

Sumana Kunnuru et al. Int J Diabetes Dev Ctries. .

Abstract

Introduction: Respiratory infections like influenza and pneumococcus increase mortality, morbidity, hospitalisation risks and healthcare costs in people with type 2 diabetes which can be prevented by vaccinations. However, there is not much data regarding how many people with type 2 diabetes in India receive pneumococcal and influenza vaccinations.

Methods: This is a cross-sectional study conducted between March 2022 to May 2022 at a tertiary care centre in South India. Patients were interviewed through face to face questionnaire regarding awareness, knowledge of influenza and pneumococcal infections, availability and need of vaccines, vaccination status and the possible reasons for not receiving vaccines.

Results: A total of 388 patients were recruited in the study. Knowledge about influenza and pneumococcal infections were present only in 4.8% and 4.1% respectively. And 98.7% of patients had no awareness about the availability and need for vaccines. Only 0.5% and 0.7% of patients received influenza and pneumococcal vaccinations respectively. After counselling and spreading awareness, 76.2% of patients said that they would receive vaccination in the next visit. Also, 23.19% of the patients refused to take any vaccinations even after counselling. And 23.7% of patients feared complications after vaccinations.

Conclusion: Pneumococcal and Influenza vaccination uptake rates are extremely low in people with type 2 diabetes in India. Urgent measures are required to increase the awareness in patients and healthcare workers about the availability, need for vaccinations and effectiveness of vaccines which would lead to improvement in vaccination rates.

Keywords: Infections; Influenza; Pneumococcus; Type 2 diabetes; Vaccination.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Awareness of influenza and pneumococcus symptoms
Fig. 2
Fig. 2
Awareness regarding vaccination in patients with diabetes
Fig. 3
Fig. 3
Beliefs of patients regarding effectiveness of vaccines
Fig. 4
Fig. 4
Sources of information regarding vaccination in diabetes
Fig. 5
Fig. 5
Reasons for not getting vaccinated
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183. - PMC - PubMed
    1. Global health estimates 2020: deaths by cause, age, sex, by country and by region, 2000–2019. Geneva: World Health Organization; 2020.
    1. Akbar DH. Bacterial pneumonia: comparison between diabetics and non-diabetics. Acta Diabetol. 2001;38:77–82. doi: 10.1007/s005920170017. - DOI - PubMed
    1. Smith SA, Poland GA. Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care. 2000;23:95–108. doi: 10.2337/diacare.23.1.95. - DOI - PubMed
    1. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9:601–610. doi: 10.1016/S1473-3099(09)70233-6. - DOI - PubMed

LinkOut - more resources